Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000919574-19-001006
Filing Date
2019-02-12
Accepted
2019-02-12 13:52:55
Documents
1
Period of Report
2019-02-08

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3993
  Complete submission text file 0000919574-19-001006.txt   5763
Mailing Address 101 PARK AVENUE NEW YORK NY 10178
Business Address 101 PARK AVENUE NEW YORK NY 10178 212-984-2500
TIGER MANAGEMENT L.L.C. (Reporting) CIK: 0001027451 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-37449 | Film No.: 19589771

Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

EIN.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations